These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22122747)

  • 21. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
    Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells.
    Tani M; Ito J; Nishioka M; Kohno T; Tachibana K; Shiraishi M; Takenoshita S; Yokota J
    Genes Chromosomes Cancer; 2004 Jun; 40(2):146-51. PubMed ID: 15101048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone acetylation and chromatin signature in stem cell identity and cancer.
    Shukla V; Vaissière T; Herceg Z
    Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy.
    Chou JL; Chen LY; Lai HC; Chan MW
    Expert Opin Ther Targets; 2010 Nov; 14(11):1213-23. PubMed ID: 20925461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetics, disease, and therapeutic interventions.
    Lu Q; Qiu X; Hu N; Wen H; Su Y; Richardson BC
    Ageing Res Rev; 2006 Nov; 5(4):449-67. PubMed ID: 16965942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-specific promoter methylation and histone modification regulate CYP19 gene expression during folliculogenesis and luteinization in buffalo ovary.
    Monga R; Ghai S; Datta TK; Singh D
    Gen Comp Endocrinol; 2011 Aug; 173(1):205-15. PubMed ID: 21663742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to analyse epigenetic marks?
    Ammerpoht O; Siebert R
    Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():511-4. PubMed ID: 22423507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromatin: a key player in complex gene regulation and future cancer therapeutics.
    Roukos DH
    Epigenomics; 2011 Aug; 3(4):395-9. PubMed ID: 22126199
    [No Abstract]   [Full Text] [Related]  

  • 29. Histone Modifications and Cancer.
    Audia JE; Campbell RM
    Cold Spring Harb Perspect Biol; 2016 Apr; 8(4):a019521. PubMed ID: 27037415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of epigenomics in ovarian and endometrial cancers.
    Balch C; Matei DE; Huang TH; Nephew KP
    Epigenomics; 2010 Jun; 2(3):419-47. PubMed ID: 22121902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic-mediated immune suppression of positive co-stimulatory molecules in chemoresistant ovarian cancer cells.
    Cacan E
    Cell Biol Int; 2017 Mar; 41(3):328-339. PubMed ID: 28074529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.
    Bapat SA; Jin V; Berry N; Balch C; Sharma N; Kurrey N; Zhang S; Fang F; Lan X; Li M; Kennedy B; Bigsby RM; Huang TH; Nephew KP
    Epigenetics; 2010; 5(8):716-29. PubMed ID: 20676026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental origins of chronic physical aggression and epigenetics.
    Tremblay RE; Szyf M
    Epigenomics; 2010 Aug; 2(4):495-9. PubMed ID: 22121967
    [No Abstract]   [Full Text] [Related]  

  • 34. Minireview: epigenetic changes in ovarian cancer.
    Balch C; Fang F; Matei DE; Huang TH; Nephew KP
    Endocrinology; 2009 Sep; 150(9):4003-11. PubMed ID: 19574400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone methylation in myelodysplastic syndromes.
    Wei Y; Gañán-Gómez I; Salazar-Dimicoli S; McCay SL; Garcia-Manero G
    Epigenomics; 2011 Apr; 3(2):193-205. PubMed ID: 22122281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetics of kidney cancer and bladder cancer.
    Hoffman AM; Cairns P
    Epigenomics; 2011 Feb; 3(1):19-34. PubMed ID: 22126150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conference Scene: epigenetics eh! The first formal meeting of the Canadian epigenetics community.
    Underhill A; Hendzel MJ
    Epigenomics; 2011 Aug; 3(4):409-15. PubMed ID: 22126202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic control in pituitary tumors.
    Ezzat S
    Endocr J; 2008 Dec; 55(6):951-7. PubMed ID: 18628575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Epigenetics and Oxidative Stress in Gliomagenesis.
    Sanchez-Perez Y; Soto-Reyes E; Garcia-Cuellar CM; Cacho-Diaz B; Santamaria A; Rangel-Lopez E
    CNS Neurol Disord Drug Targets; 2017; 16(10):1090-1098. PubMed ID: 29318979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conference Scene: Omic technologies in human disease: extending the network of epigenetic control.
    Schnekenburger M; Diederich M
    Epigenomics; 2011 Oct; 3(5):539-41. PubMed ID: 22126244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.